« Previous
Next »
Seizure: European Journal of Epilepsy
Volume 19, Issue 4
, Pages
242-246
, May 2010
Microinjection of GABAergic agents into the anterior nucleus of the thalamus modulates pilocarpine-induced seizures and status epilepticus
-
Location of the cannulae used for microinjecting GABAergic agents into the anterior nucleus of the thalamus (AN). Schematic representation of the tips of the cannulae though which 0.5
μl of muscimol 16Location of the cannulae used for microinjecting GABAergic agents into the anterior nucleus of the thalamus (AN). Schematic representation of the tips of the cannulae though which 0.5
μl of muscimol 160
nmol (
), muscimol 80
nmol (
), or bicuculline (
) were successfully injected within the AN (reprinted from Ref. 16; p. 23–26; Copyright (1998) with permission from Elsevier). Cannulae placement in animals receiving 0.2
μl injections was similar to that represented in this figure. -
GABAergic agents microinjected into the anterior nucleus of the thalamus (AN) influence the development of pilocarpine-induced seizures and status epilepticus (SE). (A and B) Animals receiving AN 160nGABAergic agents microinjected into the anterior nucleus of the thalamus (AN) influence the development of pilocarpine-induced seizures and status epilepticus (SE). (A and B) Animals receiving AN 160
nmol muscimol 0.5
μl injections (n
=
6) had a significantly increased latency to seizures and SE as compared to controls (n
=
8; p
<
0.001 and p
=
0.01). In contrast, 80
nmol muscimol injections (n
=
6) were not protective, whereas AN bicuculline (n
=
5) was proconvulsant. (C) No significant differences were observed in the percentage of animals developing SE across groups. Lines on top of the bars represent standard deviations. *Statistically significant. -
Latency for pilocarpine-induced seizures and status epilepticus (SE) in animals treated with anterior thalamic nucleus (AN) or ventricular 0.2μl muscimol injections. (A and B) Animals receiving AN 160Latency for pilocarpine-induced seizures and status epilepticus (SE) in animals treated with anterior thalamic nucleus (AN) or ventricular 0.2
μl muscimol injections. (A and B) Animals receiving AN 160
nmol muscimol (n
=
11) had a significantly increased latency to seizures and SE as compared to controls (n
=
10; p
<
0.01 and p
=
0.02). (C) In contrast, injections of 64–80
nmol (n
=
4) or 100–120
nmol (n
=
4) of ventricular muscimol were not protective. Lines on top of the bars represent standard deviations. *Statistically significant. -
Electrographic activity recorded in the cerebral cortex after pilocarpine treatment. EEG tracings showing the onset of a generalized seizure in animals treated with bilateral AN injections of saline (Electrographic activity recorded in the cerebral cortex after pilocarpine treatment. EEG tracings showing the onset of a generalized seizure in animals treated with bilateral AN injections of saline (upper trace in A) or muscimol 160
nmol (upper trace in B). In both groups, status epilepticus was characterized by continuous high-voltage fast spiking activity (lower traces in A and B). Vertical scale bar, 100
mV; horizontal scale bar, 5
s.
PII: S1059-1311(10)00053-1
doi: 10.1016/j.seizure.2010.02.010
© 2010 British Epilepsy Association. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Seizure: European Journal of Epilepsy
Volume 19, Issue 4
, Pages
242-246
, May 2010

), muscimol 80
), or bicuculline (
) were successfully injected within the AN (reprinted from